Cargando…

Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study

BACKGROUND: The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood. We aimed to investigate the prospective association of non-alcoholic fatty liver degree as well as NAFLD with incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shanshan, Yuan, Changzheng, Yang, Zhirong, Liu, Si, Zhang, Qian, Zhang, Shutian, Zhu, Shengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394037/
https://www.ncbi.nlm.nih.gov/pubmed/35989356
http://dx.doi.org/10.1186/s12916-022-02460-8
_version_ 1784771400821637120
author Wu, Shanshan
Yuan, Changzheng
Yang, Zhirong
Liu, Si
Zhang, Qian
Zhang, Shutian
Zhu, Shengtao
author_facet Wu, Shanshan
Yuan, Changzheng
Yang, Zhirong
Liu, Si
Zhang, Qian
Zhang, Shutian
Zhu, Shengtao
author_sort Wu, Shanshan
collection PubMed
description BACKGROUND: The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood. We aimed to investigate the prospective association of non-alcoholic fatty liver degree as well as NAFLD with incident IBS in a large-scale population-based cohort. METHODS: Participants free of IBS, coeliac disease, inflammatory bowel disease, alcoholic liver disease, and any cancer at baseline from the UK Biobank were included. Non-alcoholic fatty liver degree was measured by a well-validated fatty liver index (FLI), with FLI ≥ 60 as an indicator of NAFLD. Primary outcome was incident IBS. Cox proportional hazard model was used to investigate the associated risk of incident IBS. RESULTS: Among 396,838 participants (mean FLI was 48.29 ± 30.07), 153,203(38.6%) were with NAFLD diagnosis at baseline. During a median of 12.4-year follow-up, 7129 cases of incident IBS were identified. Compared with non-NAFLD, NAFLD patients showed a 13% higher risk of developing IBS (HR = 1.13, 95%CI: 1.05–1.17) after multivariable adjustment. Compared with the lowest, the highest FLI quartile was associated with a significantly increased risk of IBS (HR(Q4 VS Q1) = 1.21, 1.13–1.30, P(trend) < 0.001). Specifically, the positive association between non-alcoholic fatty liver degree and IBS was also observed by per SD change of FLI (adjusted HR = 1.08, 1.05–1.10). Further sensitivity analysis and subgroup analysis indicated similar results, with the positive association particularly observed in females, but not in males. CONCLUSIONS: High degree of non-alcoholic fatty liver as well as non-alcoholic fatty liver disease is associated with increased risk of incident IBS. Further studies are warranted to confirm the findings and elucidate the underlying biological mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02460-8.
format Online
Article
Text
id pubmed-9394037
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93940372022-08-23 Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study Wu, Shanshan Yuan, Changzheng Yang, Zhirong Liu, Si Zhang, Qian Zhang, Shutian Zhu, Shengtao BMC Med Research Article BACKGROUND: The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood. We aimed to investigate the prospective association of non-alcoholic fatty liver degree as well as NAFLD with incident IBS in a large-scale population-based cohort. METHODS: Participants free of IBS, coeliac disease, inflammatory bowel disease, alcoholic liver disease, and any cancer at baseline from the UK Biobank were included. Non-alcoholic fatty liver degree was measured by a well-validated fatty liver index (FLI), with FLI ≥ 60 as an indicator of NAFLD. Primary outcome was incident IBS. Cox proportional hazard model was used to investigate the associated risk of incident IBS. RESULTS: Among 396,838 participants (mean FLI was 48.29 ± 30.07), 153,203(38.6%) were with NAFLD diagnosis at baseline. During a median of 12.4-year follow-up, 7129 cases of incident IBS were identified. Compared with non-NAFLD, NAFLD patients showed a 13% higher risk of developing IBS (HR = 1.13, 95%CI: 1.05–1.17) after multivariable adjustment. Compared with the lowest, the highest FLI quartile was associated with a significantly increased risk of IBS (HR(Q4 VS Q1) = 1.21, 1.13–1.30, P(trend) < 0.001). Specifically, the positive association between non-alcoholic fatty liver degree and IBS was also observed by per SD change of FLI (adjusted HR = 1.08, 1.05–1.10). Further sensitivity analysis and subgroup analysis indicated similar results, with the positive association particularly observed in females, but not in males. CONCLUSIONS: High degree of non-alcoholic fatty liver as well as non-alcoholic fatty liver disease is associated with increased risk of incident IBS. Further studies are warranted to confirm the findings and elucidate the underlying biological mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02460-8. BioMed Central 2022-08-22 /pmc/articles/PMC9394037/ /pubmed/35989356 http://dx.doi.org/10.1186/s12916-022-02460-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wu, Shanshan
Yuan, Changzheng
Yang, Zhirong
Liu, Si
Zhang, Qian
Zhang, Shutian
Zhu, Shengtao
Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title_full Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title_fullStr Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title_full_unstemmed Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title_short Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
title_sort non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394037/
https://www.ncbi.nlm.nih.gov/pubmed/35989356
http://dx.doi.org/10.1186/s12916-022-02460-8
work_keys_str_mv AT wushanshan nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT yuanchangzheng nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT yangzhirong nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT liusi nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT zhangqian nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT zhangshutian nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy
AT zhushengtao nonalcoholicfattyliverisassociatedwithincreasedriskofirritablebowelsyndromeaprospectivecohortstudy